NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacyTakahiro Miyazaki, Jonathan Zalevsky, Jicai Huang et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 55
NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseasesNeha Dixit, Jonathan Zalevsky, Christie Fanton et al.|Journal of Translational Autoimmunity|2021Cited by 54
Abstract 1603: NKTR-255 engages the IL-15 pathway driving CD8 T cell survival and CD8 memory T cell proliferationPeiwen Kuo, Jonathan Zalevsky, Mekhala Maiti et al.|Cancer Research|2017Cited by 6
Pharmacokinetic and Pharmacodynamic Study of NKTR-255, a Polymer-Conjugated Human IL-15, in Cynomolgus MonkeyTakahiro Miyazaki, Jonathan Zalevsky, Peiwen Kuo et al.|Blood|2018Cited by 4
Abstract 3265: NKTR-255, a polymer-conjugated IL-15 enhances anti-tumor NK cell responses and synergizes with monoclonal antibodies to provide long-term survival in human lymphoma modelTakahiro Miyazaki, Jonathan Zalevsky, Saul Kivimäe et al.|Cancer Research|2019Cited by 0